JPH05506234A - ワクチン組成物 - Google Patents

ワクチン組成物

Info

Publication number
JPH05506234A
JPH05506234A JP91508106A JP50810691A JPH05506234A JP H05506234 A JPH05506234 A JP H05506234A JP 91508106 A JP91508106 A JP 91508106A JP 50810691 A JP50810691 A JP 50810691A JP H05506234 A JPH05506234 A JP H05506234A
Authority
JP
Japan
Prior art keywords
composition according
composition
virus
adjuvant
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP91508106A
Other languages
English (en)
Japanese (ja)
Inventor
ペニー，クリストフアー・エル
Original Assignee
ノース・アメリカン・バクシーン・インコーポレーテツド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ノース・アメリカン・バクシーン・インコーポレーテツド filed Critical ノース・アメリカン・バクシーン・インコーポレーテツド
Publication of JPH05506234A publication Critical patent/JPH05506234A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP91508106A 1990-05-07 1991-05-01 ワクチン組成物 Pending JPH05506234A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US51846090A 1990-05-07 1990-05-07
US518,460 1990-05-07
PCT/CA1991/000144 WO1991016926A1 (en) 1990-05-07 1991-05-01 Vaccine compositions

Publications (1)

Publication Number Publication Date
JPH05506234A true JPH05506234A (ja) 1993-09-16

Family

ID=24064028

Family Applications (1)

Application Number Title Priority Date Filing Date
JP91508106A Pending JPH05506234A (ja) 1990-05-07 1991-05-01 ワクチン組成物

Country Status (22)

Country Link
EP (1) EP0597838B1 (https=)
JP (1) JPH05506234A (https=)
CN (1) CN1056816A (https=)
AT (1) ATE173936T1 (https=)
AU (1) AU7777991A (https=)
CA (1) CA2082425A1 (https=)
CS (1) CS131891A3 (https=)
DE (1) DE69130576T2 (https=)
DK (1) DK0597838T3 (https=)
ES (1) ES2124701T3 (https=)
FI (1) FI925032A0 (https=)
HR (1) HRP930658A2 (https=)
HU (1) HUT65493A (https=)
IE (1) IE911527A1 (https=)
IL (1) IL97985A0 (https=)
MX (1) MX172210B (https=)
NO (1) NO924271L (https=)
NZ (1) NZ238042A (https=)
TW (1) TW221676B (https=)
WO (1) WO1991016926A1 (https=)
YU (1) YU79691A (https=)
ZA (1) ZA913214B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6620414B2 (en) 1992-03-27 2003-09-16 Smithkline Beecham Biologicals (S.A.) Hepatitis vaccines containing 3-0-deacylated monophoshoryl lipid A
MA22842A1 (fr) * 1992-03-27 1993-10-01 Smithkline Beecham Biolog Procede de preparation de compositions de vaccin.
WO1996007102A1 (en) * 1994-09-01 1996-03-07 Wisconsin Alumni Research Foundation Therapeutic remodeling in aids
FR2726471B1 (fr) * 1994-11-07 1997-01-31 Pf Medicament Procede pour ameliorer l'immunogenicite d'un compose immunogene ou d'un haptene et application a la preparation de vaccins
US6027731A (en) * 1998-11-17 2000-02-22 Wisconsin Alumni Research Foundation Pertussis toxin induced lymphocytosis
ES2299276T3 (es) 1998-12-31 2008-05-16 Novartis Vaccines And Diagnostics, Inc. Polipeptidos env del vih modificados.
AU2487300A (en) 1998-12-31 2000-07-31 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
WO2000039302A2 (en) 1998-12-31 2000-07-06 Chiron Corporation Improved expression of hiv polypeptides and production of virus-like particles
AU2002320314A1 (en) 2001-07-05 2003-01-21 Chiron, Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
ZA200502613B (en) * 2002-10-10 2006-10-25 Yeda Res & Dev Basic esters of fatty alcohols and their use as anti-inflammatory or immunomodulatory agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1138773A (en) * 1979-04-18 1983-01-04 Connaught Laboratories Limited Synthetic adjuvants for stimulation of antigenic responses
US4639371A (en) * 1984-10-02 1987-01-27 New York Blood Center, Inc. Hepatitis B antigenic compositions and vaccines against hepatitis B derived therefrom
GB8807860D0 (en) * 1988-04-05 1988-05-05 Connaught Lab Pertussis vaccine
NZ230424A (en) * 1988-08-25 1992-05-26 Liposome Co Inc Liposomal composition comprising an externally disposed antigen

Also Published As

Publication number Publication date
HU9203480D0 (en) 1993-01-28
FI925032A7 (fi) 1992-11-06
TW221676B (https=) 1994-03-11
DE69130576D1 (de) 1999-01-14
HUT65493A (en) 1994-06-28
ES2124701T3 (es) 1999-02-16
CN1056816A (zh) 1991-12-11
HRP930658A2 (en) 1997-12-31
NZ238042A (en) 1993-12-23
DK0597838T3 (da) 1999-08-16
DE69130576T2 (de) 1999-07-29
YU79691A (sh) 1994-06-10
CA2082425A1 (en) 1991-11-08
EP0597838B1 (en) 1998-12-02
MX172210B (es) 1993-12-07
FI925032L (fi) 1992-11-06
NO924271D0 (no) 1992-11-06
NO924271L (no) 1993-01-07
FI925032A0 (fi) 1992-11-06
AU7777991A (en) 1991-11-27
EP0597838A1 (en) 1994-05-25
IL97985A0 (en) 1992-06-21
ATE173936T1 (de) 1998-12-15
ZA913214B (en) 1992-09-30
IE911527A1 (en) 1991-11-20
WO1991016926A1 (en) 1991-11-14
CS131891A3 (en) 1992-02-19

Similar Documents

Publication Publication Date Title
CA1329766C (en) T cell epitopes of the hepatitis b virus nucleocapsid protein
KR100290632B1 (ko) 면역성이약한항원공액체와이를포함하는합성펩티드담체와백신
ES2207177T3 (es) Proteinas nucleo de la hepatitis b estrategicamente modificas y sus derivados.
DE68917126T2 (de) T-zellen-epitope als träger für einen konjugierten impfstoff.
Chong et al. A strategy for rational design of fully synthetic glycopeptide conjugate vaccines
HUT64237A (en) Improved vaccina preparatives
US5019383A (en) Fatty acid carriers for synthetic peptides
JPH09510975A (ja) アレルギー治療用合成ペプチドベース免疫原
CN104507496B (zh) 包含与crm197载体蛋白偶联的hiv gp41肽的免疫原性化合物
JPH05506234A (ja) ワクチン組成物
AU4100800A (en) Method for down-regulating il5 activity
US4694071A (en) Polypeptides useful in vaccination against enteroviruses
US4584195A (en) Broad spectrum vaccine against gonorrhea
US12350331B2 (en) Bivalent dengue/hepatitus B vaccines
JP4099059B2 (ja) 特定交叉反応性を高める抗原構造を得る方法
US4622223A (en) Broad spectrum vaccine against gonorrhea
ES2315405T3 (es) Proteina pre-s del virus de la hepatitis b (vhb) como adyuvante y un componente de una vacuna frente a vhb.
Penney et al. Further studies on the adjuvanticity of stearyl tyrosine and ester analogues
JPS6399018A (ja) 複合免疫原
JP2001505763A (ja) Ｈｉｖ ｐ―１７ペプチドフラグメント、それを含有する組成物並びにその製造及び使用方法
HK1058154B (en) Method for obtaining antigenic structures enhancing specific cross reactivity
HK1056825A (en) Method for obtaining antigenic structures enhancing specific cross reactivity